Synagis

394,00 

Therapeutic RSV protein F-antibody from the original Synagis commercial drug targeting the RSV protein F-antigen, also referred to as Synagis antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Storage [°C] Original therapeutic expiry date [see Note 1] CoA [see Note 2] PriceQuantityTotal
aliquot 100404382291-80°04/2019yes 394,00 
-
+
394,00 
spinner
aliquot 100404382445-80°06/2019yes 394,00 
-
+
394,00 
spinner
aliquot 100404382615-80°10/2019yes 394,00 
-
+
394,00 
spinner
aliquot 100404382683-80°02/2020yes 394,00 
-
+
394,00 
spinner
aliquot 1004043828352-8°/-80°08/2020yes 394,00 
-
+
394,00 
spinner

Category: SKU: Synagis

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Palivizumab

Antigen

RSV protein F

Product Concentration [mg/mL]

1, 100

Volume per Vial [µL]

40, 100

Quantity per vial [mg]

0, 0,1, 4

Batch Number

NOT APPLICABLE, -, 382291, 382445, 382615, 382683, 382835

Storage [°C]

-, -80°, 2-8°/-80°

Original therapeutic expiry date [see Note 1]

-, 02/2020, 04/2019, 06/2019, 08/2020, 10/2019, NOT APPLICABLE

CoA [see Note 2]

n.a., no, yes

You may also like…